Richard Riedel, MD

Associate Director, Clinical Research

Overview

Sarcomas are a diverse and relatively rare group of malignant tumors that develop in soft tissue and bone. Soft tissue and bone sarcoma incidence rates, according to the National Cancer Institute, have increased over the past 35 years, with soft tissue sarcomas more common.

Duke Cancer Institute’s Sarcoma disease group uses a multidisciplinary, patient-centric approach to diagnose and treat both bone and soft-tissue sarcomas. Through unsurpassed clinical care, personalized treatment planning and delivery, and state-of-the-art basic scientific and clinical research, the program is the center of excellence for the treatment of sarcoma in the Southeast and beyond.

Our strengths include:

  • A multidisciplinary clinic
  • Prospective multidisciplinary database
  • Monthly multidisciplinary research conferences
  • Weekly multidisciplinary clinical case conferences
  • Internationally recognized sarcoma research program
  • An annual run/walk event —Strike Out for Sarcoma — to raise research support for the program

Download our Duke Cancer Patient Resource Guide.

Make An Appointment

To make an appointment, please call 919.613.5550. For more information on sarcoma cancer care at Duke Health, visit Sarcoma. To find a doctor, visit Find A Specialist.

 

Research

So Young Kim, PhD (right) updates Jason Somarelli, PhD, on the progress of testing thousands of drugs on human and canine sarcoma cell lines. (click photo to read about their research)So Young Kim, PhD (right) updates Jason Somarelli, PhD, on the progress of testing thousands of drugs on human and canine sarcoma cell lines. (click photo to read about their research)We have created a robust basic, translational and clinical research portfolio.

With a goal to fast-track the design and approval of clinical trials, our scientists are leading the way in the research of sarcoma and studying the cancer in children as well as adults. We aim to have a clinical trial option for every patient.

We are investigating, in the lab, possible agents to fight rhabdomyosarcoma and other sarcoma subtypes.

Clinical Trials

Our researchers have conducted and are conducting several sarcoma-specific clinical trials, including pharmaceutically-sponsored, investigator-initiated and cooperative group trials.

Search Our Clinical Trials or email Duke Sarcoma Oncology Clinical Trials.

Additional Contacts

Eugene Rossitch, MHA, Administrative Director
Phone: 919.613.0729

Colleen Piechocki RN, BSN, Senior Clinical Research Nurse Coordinator
Phone: 919.681.1883